메뉴 건너뛰기




Volumn 35, Issue 2, 2012, Pages 88-89

Restless legs syndrome responsive to rasagiline treatment: A case report

Author keywords

Parkinson disease; rasagiline; restless legs syndrome

Indexed keywords

RASAGILINE;

EID: 84858785296     PISSN: 03625664     EISSN: 1537162X     Source Type: Journal    
DOI: 10.1097/WNF.0b013e31824c1c3f     Document Type: Article
Times cited : (6)

References (15)
  • 2
    • 0141632710 scopus 로고    scopus 로고
    • Restless legs syndrome and PD: A review of the evidence for a possible association
    • Garcia-Borreguero D, Odin P, Serrano C. Restless legs syndrome and PD: a review of the evidence for a possible association. Neurology 2003;61(6 suppl 3):S49-S55. (Pubitemid 37151646)
    • (2003) Neurology , vol.61 , Issue.SUPPL. 3
    • Garcia-Borreguero, D.1    Odin, P.2    Serrano, C.3
  • 3
    • 0036186469 scopus 로고    scopus 로고
    • Exploring the relationship between Parkinson disease and restless legs syndrome
    • Ondo WG, Vuong KD, Jankovic J. Exploring the relationship between Parkinson disease and restless legs syndrome. Arch Neurol 2002;59:421-424. (Pubitemid 34208151)
    • (2002) Archives of Neurology , vol.59 , Issue.3 , pp. 421-424
    • Ondo, W.G.1    Vuong, K.D.2    Jankovic, J.3
  • 5
    • 0032816549 scopus 로고    scopus 로고
    • The substantia nigra of the human brain: II. Patterns of loss of dopamine-containing neurons in Parkinson's disease
    • DOI 10.1093/brain/122.8.1437
    • Damier P, Hirsch EC, Agid Y, et al. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 1999;122:1437-1448. (Pubitemid 29374122)
    • (1999) Brain , vol.122 , Issue.8 , pp. 1437-1448
    • Damier, P.1    Hirsch, E.C.2    Agid, Y.3    Graybiel, A.M.4
  • 6
    • 0037176802 scopus 로고    scopus 로고
    • Restless legs syndrome: Treatment with dopaminergic agents
    • Comella CL. Restless legs syndrome: treatment with dopaminergic agents. Neurology 2002;58(suppl 1):S887-S892.
    • (2002) Neurology , vol.58 , Issue.SUPPL. 1
    • Comella, C.L.1
  • 7
    • 79957603259 scopus 로고    scopus 로고
    • Milestones in Parkinson's disease therapeutics
    • Rascol O, Lozano A, Stern M, et al. Milestones in Parkinson's disease therapeutics. Mov Disord 2011;26:1072-1082.
    • (2011) Mov Disord , vol.26 , pp. 1072-1082
    • Rascol, O.1    Lozano, A.2    Stern, M.3
  • 8
    • 0036894795 scopus 로고    scopus 로고
    • A controlled trial of rasagiline in early Parkinson disease: The TEMPO Study
    • Parkinson Study Group. A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study. Arch Neurol 2002;59:1937-1943.
    • (2002) Arch Neurol , vol.59 , pp. 1937-1943
    • Study Group, P.1
  • 9
  • 10
    • 60549085946 scopus 로고    scopus 로고
    • Overview of the extranigral aspects of Parkinson disease
    • Lim SY, Fox SH, Lang AE. Overview of the extranigral aspects of Parkinson disease. Arch Neurol 2009;66:167-172.
    • (2009) Arch Neurol , vol.66 , pp. 167-172
    • Lim, S.Y.1    Fox, S.H.2    Lang, A.E.3
  • 11
    • 61449256613 scopus 로고    scopus 로고
    • Treatment of restless legs syndrome: An evidence-based review and implications for clinical practice
    • Trenkwalder C, Heninig WA, Montagna P, et al. Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice. Mov Disord 2008;23:2267-2302.
    • (2008) Mov Disord , vol.23 , pp. 2267-2302
    • Trenkwalder, C.1    Heninig, W.A.2    Montagna, P.3
  • 15
    • 0742306162 scopus 로고    scopus 로고
    • Augmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS)
    • DOI 10.1016/j.sleep.2003.07.005, PII S138994570300203X
    • Winkelman JW, Johnston L. Augmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS). Sleep Med 2004;5:9-14. (Pubitemid 38145706)
    • (2004) Sleep Medicine , vol.5 , Issue.1 , pp. 9-14
    • Winkelman, J.W.1    Johnston, L.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.